OsteoNovus, Inc.

OsteoNovus is an orthopedic medical device company specializing in synthetic calcium phosphate-based bone substitutes for regenerative bone repair. The company's proprietary NovoGro technology delivers bioactive, moldable putty and injectable formulations designed for bone void filling, fracture treatment, and spinal surgery applications. NovoGro's biomimetic apatite surface promotes rapid bone remodeling and replacement, with clinical evidence demonstrating substantial new trabecular bone formation within 6 weeks post-implantation. The material exhibits superior handling characteristics—moldability, wet-bone adhesion, compression resistance, and no-wash-out stability—while maintaining FDA clearance for orthopedic and spine applications. NovoGro is available in putty, granule, and structural block formats, with an injectable variant currently in development. The company is now operational in both the US and Canadian markets.